Please use this identifier to cite or link to this item:

TitleBiodegradable drug-eluting stents: targeting urothelial tumors of upper urinary tract
Author(s)Barros, Alexandre António Antunes
Browne, S.
Oliveira, C.
Reis, R. L.
Duarte, Ana Rita C.
Healy, K. E.
Lima, Estêvão Augusto Rodrigues de
Urothelial cancer
Issue date2016
CitationBarros A. A., Browne S., Oliveira C., Reis R. L., Duarte A. R. C., Healy K. E., Lima E. Biodegradable drug-eluting stents: Targeting urothelial tumors of upper urinary tract, Journal of Urology, doi:10.1016/j.juro.2016.02.729, 2016
Abstract(s)Urothelial tumors of upper urinary tract are ranked among the most common types of cancers worldwide. The current standard therapy to prevent recurrence is intravesical Bacillus-Calmetteâ Guerin (BCG) immunotherapy, but it presents several disadvantages such as BCG failure and intolerance. Another way is to use chemotherapy, which is generally better tolerated that BCG. In this case, drugs such as epirubicin, doxorubicin, paclitaxel and gemcitabine are used. Nevertheless, intravesical chemotherapy only prevents recurrence in the short-term.
Publisher version
AccessOpen access
Appears in Collections:3B’s - Resumos em livros de atas de conferências - indexados no ISI Web of Science

Files in This Item:
File Description SizeFormat 
18739-PIIS002253471601017X.pdf739,92 kBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID